Superior reagents are key to developing high quality clinical diagnostic products.  Spectral innovations are realized by a strong molecular biology and protein chemistry team.  Using principles of recombinant technology Spectral has successfully engineered and produced over 30 antigens in bacteria and has created several patented novel molecules, which show superior performance over their native counterparts.

Spectral's single-chain Troponin I-C polypeptide has been recognized by the market as the best calibrator and control material for cardiac Troponin I immunoassays.  The same material has been selected by the American Association of Clinical Chemistry as one of the three candidate international standard materials for Troponin I immunoassays. 

Spectral's R&D team is organized into specialized groups and the interaction among groups is project oriented.  Spectral scientists are additionally trained by periodic scientific seminars and by attending scientific workshops and conferences.  Spectral's projects are managed following ISO 9001 standards and the performance of Spectral's quality system is monitored by regular internal and external quality audits.